The FT Weekend, one of the most read financial broadsheets worldwide, featured on its front page the first brain implant made of graphene that is set to begin clinical trials at NHS Salford Royal in Manchester imminently.

“The primary objective of this ‘first in-human’ trial is to demonstrate the safety of graphene electrodes applied to the brain in eight to ten patients” quotes Kostas, the Chief Scientific Investigator of the CORDOBA trial. Our long-term collaborator, neurosurgeon Dr David Coope is the Chief Clinical Investigator.